Back to search
Acute Decompensation in Liver Cirrhosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Decompensation in Liver Cirrhosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Decompensation in Liver Cirrhosis trials you may qualify forThe purpose of this study is to identify factors that predict the development of decompensation, acute-on-chronic liver failure (ACLF) and death in patients wit…
Patients with liver cirrhosis have historically received prophylactic transfusions before invasive procedures with high risk of bleeding. The optimal method for…
The study aims to test the effectiveness of new biomarkers (measurable molecules in our body) in predicting the health outcome of patients with liver cirrhosis…
Cirrhotic patients are at higher risk of sepsis due to impaired innate and adaptive immune responses. Septic complications represent a major issue in the manage…
A Phase 2, multi-center, randomized, controlled, open-label study to evaluate the effects of the intraperitoneal, liposomal formulation VS-01 in patients with a…
A Phase 2, Randomized, Controlled, Open-Label, Adaptive Dose Design, Proof-of-Concept Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Two Differ…